Evidence supports combination therapy for treating fibromyalgia pain

Posted 06 Nov, 2016 [ssba]

A study has found a combination of the pain drugs pregabalin and duloxetine to be more effective than monotherapy in relieving fibromyalgia pain. The findings, published in Pain, provide support for combination therapy, which is commonly used in this patient population despite a lack of strong evidence for the practice, the investigators wrote. They noted that previous trials have tended to examine pain reduction using monotherapy.

The investigators conducted a single-center, randomized controlled trial comparing the effectiveness of pregabalin (Lyrica, Pfizer) and duloxetine (Cymbalta, Lilly) with that of each drug individually, as well as with placebo (Pain 2016;157:1532-1540). They recruited 41 patients with fibromyalgia (age range, 18-70 years) between April 2011 and September 2014. All the patients had experienced daily pain of 4 or higher on a scale of 0 to 10 for at least three months before recruitment. In addition to study medications, the participants were given previously prescribed analgesics, including acetaminophen, nonsteroidal anti-inflammatory drugs and opioids.

Please click the link below to read further:

http://www.painmedicinenews.com/Clinical-Pain-Medicine/Article/10-16/Evidence-Supports-Combination-Therapy-For-Treating-Fibromyalgia-Pain/37997

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 07 Feb, 2019

Stellate Ganglion Block a Potential Lifesaver in Severe PTSD

Case reports are mounting of immediate, durable, and significant relief of severe refractory symptoms of posttraumatic stress disorder (PTSD), according to an anesthesiologist who has seen the benefits firsthand. Stellate ganglion blockade (SGB) “seems to significantly improve PTSD symptoms as well as significant...
Posted 25 Jan, 2019

CGRP Antagonists: A new era for migraine treatment

Migraine is a common medical condition, affecting as many as 37 million people in the US. It is considered a systemic illness, not just a headache. Recent research has demonstrated that changes may begin to occur in the brain as long as 24 hours before migraine symptoms begin. Many patients have a severe throbbing head...